Advertisement
U.S. markets closed

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
4.4300-0.0500 (-1.12%)
At close: 04:00PM EDT
4.4400 +0.01 (+0.23%)
After hours: 05:54PM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
Operating Expense
33,657
21,257
57,515
6,764
Operating Income
-33,657
-21,257
-57,515
-6,764
Net Non Operating Interest Income Expense
135
284
-680
-3,320
Other Income Expense
200
89
182
-18,212
Pretax Income
-33,322
-20,884
-58,013
-28,296
Tax Provision
0
-
-
-
Net Income Common Stockholders
-33,322
-20,884
-58,013
-28,296
Diluted NI Available to Com Stockholders
-33,322
-20,884
-58,013
-28,296
Basic EPS
-9.00
-19.80
-61.80
-193.50
Diluted EPS
-9.00
-19.80
-61.80
-193.50
Basic Average Shares
1,272
1,062
938.52
146.174
Diluted Average Shares
1,272
1,062
938.52
146.174
Total Operating Income as Reported
-33,657
-21,257
-57,515
-6,764
Total Expenses
33,657
21,257
57,515
6,764
Net Income from Continuing & Discontinued Operation
-33,322
-20,884
-58,013
-28,296
Normalized Income
-33,522
-20,973
-58,195
-22,682
Interest Income
157
292
38
0
Interest Expense
22
8
718
3,320
Net Interest Income
135
284
-680
-3,320
EBIT
-33,300
-20,876
-57,295
-24,976
EBITDA
-33,300
-20,876
-57,295
-24,976
Reconciled Depreciation
12
-
-
0
Net Income from Continuing Operation Net Minority Interest
-33,322
-20,884
-58,013
-28,296
Total Unusual Items Excluding Goodwill
200
89
182
-5,614
Total Unusual Items
200
89
182
-5,614
Normalized EBITDA
-33,500
-20,965
-57,477
-19,362
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0